½ÃÀ庸°í¼­
»óǰÄÚµå
1586177

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå : Á¦Ç°, ¿ëµµ ¹× ÃÖÁ¾ »ç¿ëÀÚº° - ¼¼°è ¿¹Ãø(2025-2030³â)

Cell Culture Reagents Market by Product (Antibiotic, Buffer, Cryoprotective), Application (Bioproduction, Diagnostics, Research), End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 187 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀº 2023³â¿¡ 93¾ï 5,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 105¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR) 13.38%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 225¾ï 4,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼Æ÷¹è¾ç ½Ã¾àÀº ½ÃÇè°ü ³» ¼¼Æ÷ÀÇ ¼ºÀå°ú À¯Áö¿¡ »ç¿ëµÇ´Â ¹°ÁúÀ» ¸»Çϸç, °úÇÐ ¿¬±¸, ¹ÙÀÌ¿À ÀǾàǰ ¹× Áø´Ü¿¡ ÇʼöÀûÀÎ Çʼö ¿µ¾ç¼Ò¿Í ȯ°æ Á¶°ÇÀ» Á¦°øÇÕ´Ï´Ù. ¼¼Æ÷¹è¾ç ½Ã¾àÀÇ Çʿ伺Àº »ý¸®Àû Á¶°ÇÀ» ½Ã¹Ä·¹À̼ÇÇÏ´Â ´É·Â¿¡ ÀÖÀ¸¸ç, ±× °á°ú ¼¼Æ÷ Çൿ ¿¬±¸, ¾à¹° ½ºÅ©¸®´×, ¹é½Å ¹× Ç×ü¿Í °°Àº »ý¹°ÇÐÀû Á¦Á¦ Á¦Á¶¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã¾àÀº Çмú ¿¬±¸, Á¦¾à, »ý¸í°øÇÐ, ÀÓ»ó Áø´Ü¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖÀ¸¸ç, ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â ¿¬±¸¼Ò, Çмú ±â°ü ¹× »ý¸í°øÇÐ ±â¾÷ÀÔ´Ï´Ù. ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀº ¹ÙÀÌ¿À ÀǾàǰ¿¡ ´ëÇÑ ÀÇÁ¸µµ Áõ°¡, ¾Ï ¿¬±¸ÀÇ ¹ßÀü, 3D ¼¼Æ÷¹è¾ç ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú ÇÔ²² ´ÜŬ·ÐÇ×ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ÈûÀÔ¾î ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¹«Ç÷û ¹èÁö, ÀÚµ¿È­ ±â¼ú µµÀÔ, °³ÀÎ ¸ÂÃãÇü ÀÇ·á¿Í °°Àº Çõ½ÅÀº ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. Áö¼Ó °¡´ÉÇϰí À±¸®ÀûÀÎ ¿¬±¸ ¹æ¹ýÀ¸·ÎÀÇ ÀüȯÀº ½Ä¹° À¯·¡ ½Ã¾à°ú ÇÕ¼º ´ëüǰ¿¡ ´ëÇÑ Å½±¸¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ³ôÀº ½Ã¾à ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, ¼¼Æ÷¹è¾ç ±â¼ú°ú °ü·ÃµÈ ±â¼úÀû º¹À⼺ µîÀÌ ½ÃÀå ¼ºÀåÀÇ Á¦¾à ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¿¬±¸ °á°úÀÇ Ç°Áú°ú ½Å·Ú¼ºÀ» ÈѼÕÇÏ´Â À§Á¶µµ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷µéÀº ƯÁ¤ ¿¬±¸ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ ¸ÂÃãÇüÀ» °­Á¶Çϰí, ºñ¿ë È¿À²ÀûÀÌ°í °íǰÁúÀÇ ½Ã¾à °³¹ß¿¡ ÁýÁßÇØ¾ß ÇÕ´Ï´Ù. ÇÐ°è ¹× ¿¬±¸ ±â°ü°úÀÇ Çù·ÂÀº Çõ½ÅÀ» ÃËÁøÇÏ°í ½ÃÀå ¹üÀ§¸¦ È®´ëÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. À¯¸ÁÇÑ ¿¬±¸ ºÐ¾ß·Î´Â CRISPR ¹× À¯ÀüÀÚ ÆíÁý ±â¼ú¿¡ ÀûÇÕÇÑ ½Ã¾à °³¹ß, in vivo Å×½ºÆ®¸¦ ´ëüÇÒ ¼ö ÀÖ´Â Àå±â ¿ÂĨ ½Ã½ºÅÛ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù. ½ÃÀåÀº °è¼Ó ¿ªµ¿ÀûÀ̰í Áö¼ÓÀûÀÎ ¹ßÀüÀÌ »óȲÀ» Çü¼ºÇϰí ÀÖÀ¸¸ç, ±â¾÷Àº Áö¼ÓÀûÀ¸·Î ÀûÀÀÇÏ°í °æÀï ¿ìÀ§¸¦ À¯ÁöÇÏ°í ¼ºÀåÀ» °¡¼ÓÇϱâ À§ÇØ ¿¬±¸ °³¹ß¿¡ ÅõÀÚÇØ¾ß ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 93¾ï 5,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 105¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 225¾ï 4,000¸¸ ´Þ·¯
CAGR(%) 13.38%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ ¿ÏÈ­Çϰí, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¦¾à ¹× »ý¸í°øÇÐ »ê¾÷ÀÇ ¼ºÀå
    • ¹é½Å ¿¬±¸ °³¹ß Ȱµ¿¿¡ ´ëÇÑ Á¤ºÎ ÅõÀÚ
    • ¾Ï ¹× ±âŸ ¸¸¼º ÁúȯÀÇ À¯Çà
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼¼Æ÷ ÇÁ·ÎÆÄÀϸµ ¹× ¹è¾ç¿¡ µå´Â ³ôÀº ºñ¿ë°ú ¼¼Æ÷¹è¾ç ó¸®ÀÇ ¾î·Á¿ò
  • ½ÃÀå ±âȸ
    • À̹Ì¡ ºÐ¼®¿¡¼­ Çü±¤ ½ÅÈ£¸¦ °­È­ÇÏ´Â »õ·Î¿î ½Ã¾à °³¹ß
    • 3D ¼¼Æ÷¹è¾ç°ú Áٱ⼼Æ÷ ±â¼úÀÇ ¹ßÀü
  • ½ÃÀå °úÁ¦
    • À¯µ¶¼º ±¤ºÐÇØ ¹ß»ý ¹× ¼¼Æ÷ÁÖ ¿À¿° °¡´É¼º ³ôÀ½

Portre's Five Forces: ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå¿¡¼­°æÀï ±¸µµ ÆÄ¾Ç

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå¿¡¼­ °ø±Þ¾÷ü¸¦ Æò°¡ÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå¿¡¼­ÀÇ ¼º°ø Àü·« ºÐ¼® ¹× Ãßõ ½Ã¾à ½ÃÀå¿¡¼­ÀÇ ¼º°ø °æ·Î¸¦ ±×¸®´Ù.

¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀåÀÇ Àü·«Àû ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå : Á¦Ç°º°

  • Ç×»ýÁ¦
  • ¹öÆÛ
  • µ¿°á ¹æÁöÁ¦
  • ¼ºÀåÀÎÀÚ ¹× »çÀÌÅäÄ«ÀÎ
  • º¸Ãæ

Á¦7Àå ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå : ¿ëµµº°

  • ¹ÙÀÌ¿ÀÇÁ·Î´ö¼Ç
    • Ç×ü
    • ´Ü¹éÁú
    • ¹é½Å
  • Áø´Ü
  • ¿¬±¸

Á¦8Àå ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ÀǾàǰ
  • ¿¬±¸±â°ü

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¼¼Æ÷¹è¾ç ½Ã¾à ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Agilent Technologies, Inc.
  • Ajinomoto Co., Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Cell Applications, Inc.
  • Corning Incorporated
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • FUJIFILM Holdings America Corporation
  • HiMedia Laboratories Pvt. Ltd.
  • InvivoGen
  • LGC Limited
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec
  • Promega Corporation
  • PromoCell GmbH
  • Qiagen N.V.
  • R&D Systems, Inc.
  • Rockland Immunochemicals, Inc.
  • Santa Cruz Biotechnology, Inc
  • Sartorius AG
  • STEMCELL Technologies Inc.
  • Thermo Fisher Scientific Inc.
LSH

The Cell Culture Reagents Market was valued at USD 9.35 billion in 2023, expected to reach USD 10.57 billion in 2024, and is projected to grow at a CAGR of 13.38%, to USD 22.54 billion by 2030.

Cell culture reagents refer to substances used in the growth and maintenance of cells in vitro, providing essential nutrients and environmental conditions crucial for scientific research, biopharmaceuticals, and diagnostics. The necessity of cell culture reagents lies in their ability to simulate physiological conditions, thus enabling the study of cellular behaviors, drug screening, and production of biologics like vaccines and antibodies. These reagents find extensive applications in academic research, pharmaceuticals, biotechnology, and clinical diagnostics, with key end-users being research laboratories, academic institutions, and biotech companies. The market for cell culture reagents is driven by the increasing demand for monoclonal antibodies, advancements in cancer research, and the growing reliance on biopharmaceuticals coupled with rapid developments in 3D cell culture techniques. Innovations such as serum-free culture media, the incorporation of automated technologies, and personalized medicine offer lucrative opportunities for growth. The shift towards sustainable and ethical research practices further encourages the exploration of plant-based reagents and synthetic alternatives. However, market growth is constrained by the high cost of reagents, stringent regulatory requirements, and the technical complexities involved in cell culture techniques. Counterfeiting also presents a challenge, compromising the quality and reliability of research outcomes. To capitalize on opportunities, companies should focus on developing cost-effective, high-quality reagents, emphasizing customization to cater to specific research needs. Partnering with academic and research institutions could facilitate innovation and expand market reach. Promising areas of research include the development of reagents compatible with CRISPR and gene-editing technologies, as well as innovations in organ-on-chip systems which offer alternatives to in vivo testing. The market will continue to be dynamic, with sustained advancements shaping the landscape, requiring businesses to continuously adapt and invest in research and development to maintain competitive advantages and drive growth.

KEY MARKET STATISTICS
Base Year [2023] USD 9.35 billion
Estimated Year [2024] USD 10.57 billion
Forecast Year [2030] USD 22.54 billion
CAGR (%) 13.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cell Culture Reagents Market

The Cell Culture Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growth In pharmaceutical and biotechnology industries
    • Government investment in vaccine research and development activities
    • Prevalence of cancer and other chronic diseases
  • Market Restraints
    • High cost of cell profiling and culture and difficulties in cell culture handling
  • Market Opportunities
    • Emerging development in reagents that enhance fluorescent signals in imaging assays
    • Advancements in 3D cell culture and stem cell technology
  • Market Challenges
    • Occurrence of toxic photolysis and higher chance of cell line contaminations

Porter's Five Forces: A Strategic Tool for Navigating the Cell Culture Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cell Culture Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cell Culture Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cell Culture Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cell Culture Reagents Market

A detailed market share analysis in the Cell Culture Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cell Culture Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cell Culture Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cell Culture Reagents Market

A strategic analysis of the Cell Culture Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cell Culture Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Ajinomoto Co., Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Cell Applications, Inc., Corning Incorporated, Danaher Corporation, F. Hoffmann-La Roche AG, FUJIFILM Holdings America Corporation, HiMedia Laboratories Pvt. Ltd., InvivoGen, LGC Limited, Lonza Group AG, Merck KGaA, Miltenyi Biotec, Promega Corporation, PromoCell GmbH, Qiagen N.V., R&D Systems, Inc., Rockland Immunochemicals, Inc., Santa Cruz Biotechnology, Inc, Sartorius AG, STEMCELL Technologies Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Cell Culture Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Antibiotic, Buffer, Cryoprotective, Growth Factors & Cytokines, and Supplement.
  • Based on Application, market is studied across Bioproduction, Diagnostics, and Research. The Bioproduction is further studied across Antibody, Protein, and Vaccine.
  • Based on End-User, market is studied across Pharmaceuticals and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growth In pharmaceutical and biotechnology industries
      • 5.1.1.2. Government investment in vaccine research and development activities
      • 5.1.1.3. Prevalence of cancer and other chronic diseases
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cell profiling and culture and difficulties in cell culture handling
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging development in reagents that enhance fluorescent signals in imaging assays
      • 5.1.3.2. Advancements in 3D cell culture and stem cell technology
    • 5.1.4. Challenges
      • 5.1.4.1. Occurrence of toxic photolysis and higher chance of cell line contaminations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cell Culture Reagents Market, by Product

  • 6.1. Introduction
  • 6.2. Antibiotic
  • 6.3. Buffer
  • 6.4. Cryoprotective
  • 6.5. Growth Factors & Cytokines
  • 6.6. Supplement

7. Cell Culture Reagents Market, by Application

  • 7.1. Introduction
  • 7.2. Bioproduction
    • 7.2.1. Antibody
    • 7.2.2. Protein
    • 7.2.3. Vaccine
  • 7.3. Diagnostics
  • 7.4. Research

8. Cell Culture Reagents Market, by End-User

  • 8.1. Introduction
  • 8.2. Pharmaceuticals
  • 8.3. Research Institutes

9. Americas Cell Culture Reagents Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cell Culture Reagents Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cell Culture Reagents Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Ajinomoto Co., Inc.
  • 3. Becton, Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. Bio-Techne Corporation
  • 6. Cell Applications, Inc.
  • 7. Corning Incorporated
  • 8. Danaher Corporation
  • 9. F. Hoffmann-La Roche AG
  • 10. FUJIFILM Holdings America Corporation
  • 11. HiMedia Laboratories Pvt. Ltd.
  • 12. InvivoGen
  • 13. LGC Limited
  • 14. Lonza Group AG
  • 15. Merck KGaA
  • 16. Miltenyi Biotec
  • 17. Promega Corporation
  • 18. PromoCell GmbH
  • 19. Qiagen N.V.
  • 20. R&D Systems, Inc.
  • 21. Rockland Immunochemicals, Inc.
  • 22. Santa Cruz Biotechnology, Inc
  • 23. Sartorius AG
  • 24. STEMCELL Technologies Inc.
  • 25. Thermo Fisher Scientific Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦